Patent ID: 7094800

Claim:
A compound of the formula I, wherein R1 is H, (C 1 –C 10 )-alkyl, (C 3 –C 10 )-cycloalkyl, (C 2 –C 6 )-alkenyl, (C 2 –C 6 )-alkynyl, (C 6 –C 10 )-aryl, heterocyclyl, COR3, COOR3, CONR3R4 or CN, wherein said (C 1 –C 10 )-alkyl, (C 3 –C 10 )-cycloalkyl, (C 2 –C 6 )-alkenyl, (C 2 –C 6 )-alkynyl, (C 6 –C 10 )-aryl and heterocyclyl radicals are optionally substituted one or more times by F, Cl, Br, I, CN, NO 2 , SH, SF 5 , OH, (C 1 –C 6 )-alkyl, —CF 3 , (C 2 –C 6 )-alkenyl, (C 2 –C 6 )-alkynyl, OR3, OP(O)(OR3) 2 , NR3R4, NR3CONR3R4, COR3, OCOR3, OCOOR3, COOR3, CONR3R4, OCONR3R4, (C 1 –C 6 )-alkylene-OR3, (C 1 –C 6 )-alkylene-NR3R4, (C 1 –C 6 )-alkylene-NR3SO 2 R4, (C 1 –C 6 )-alkylene-SR3, alkylene-S(O)R3, alkylene-S(O) 2 R3, alkylene-S(O) 2 NR3R4, (C 1 –C 6 )-alkylene-COR3, (C 1 –C 6 )-alkylene-COOR3, (C 1 –C 6 )-alkylene-CONR3R4, SR3, SOR3, SO 2 R3, SO 2 NR3R4, NR3SO 2 R4, (C 1 –C 6 )-alkylene-(C 3 –C 10 )-cycloalkyl, (C 1 –C 6 )-alkylene-(C 6 –C 10 )-aryl, (C 1 –C 6 )-alkylene-heterocyclyl, (C 3 –C 10 )-cycloalkyl, (C 6 –C 10 )-aryl or heterocyclyl; R2 is H, (C 1 –C 10 )-alkyl, (C 3 –C 10 )-cycloalkyl, (C 2 –C 6 )-alkenyl, (C 2 –C 6 )-alkynyl, (C 6 –C 10 )-aryl, heterocyclyl, COR3, COOR3, CONR3R4 or CN, wherein said (C 1 –C 10 )-alkyl, (C 3 –C 10 )-cycloalkyl, (C 2 –C 6 )-alkenyl, (C 2 –C 6 )-alkynyl, (C 6 –C 10 )-aryl and heterocyclyl radicals are optionally substituted one or more times by F, Cl, Br, I, CN, NO 2 , SH, SF 5 , OH, (C 1 –C 6 )-alkyl, —CF 3 , (C 2 –C 6 )-alkenyl, (C 2 –C 6 )-alkynyl, OR3, OP(O)(OR3) 2 , NR3R4, NR3CONR3R4, COR3, OCOR3, OCOOR3, COOR3, CONR3R4, OCONR3R4, (C 1 –C 6 )-alkylene-OR3, (C 1 –C 6 )-alkylene-NR3R4, (C 1 –C 6 )-alkylene-NR3SO 2 R4, (C 1 –C 6 )-alkylene-SR3, alkylene-S(O)R3, alkylene-S(O) 2 R3, alkylene-S(O) 2 NR3R4, (C 1 –C 6 )-alkylene-COR3, (C 1 –C 6 )-alkylene-COOR3, (C 1 –C 6 )-alkylene-CONR3R4, SR3, SOR3, SO 2 R3, SO 2 NR3R4, NR3SO 2 R4, (C 1 –C 6 )-alkylene-(C 3 –C 10 )-cycloalkyl, (C 1 –C 6 )-alkylene-(C 6 –C 10 )-aryl, (C 1 –C 6 )-alkylene-heterocyclyl, (C 3 –C 10 )-cycloalkyl, (C 6 –C 10 )-aryl or heterocyclyl; R3, R4 are each, independently of one another, H, (C 1 –C 6 )-alkyl, —CF 3 , (C 3 –C 10 )-cycloalkyl, (C 6 –C 10 )-aryl, heterocyclyl, (C 1 –C 6 )-alkylene-CONR5R6, CONR5R6, (C 1 –C 6 )-alkylene-COOR5, COOR5, COR5, (C 1 –C 6 )-alkylene-COR5, (C 1 –C 6 )-alkylene-OR5, (C 1 –C 6 )-alkylene-NR5R6, (C 1 –C 6 )-alkylene-SR5, (C 1 –C 6 )-alkylene-S(O)R5, (C 1 –C 6 )-alkylene-S(O) 2 R5, S(O)R5, S(O) 2 R5, (C 1 –C 4 )-alkylene-(C 6 –C 10 )-aryl or (C 1 –C 4 )-alkylene-heterocyclyl; R5, R6 are each, independently of one another, H, (C 1 –C 6 )-alkyl, (C 1 –C 6 )-alkylene-(C 6 –C 10 )-aryl, —(C 6 –C 10 )-aryl, heterocyclyl or (C 1 –C 6 )-alkylene-heterocyclyl; and pharmaceutically acceptable salts thereof.